CHANGZHOU PHARMACEUTICAL FACTORY
PharmaCHANGZHOU PHARMACEUTICAL FACTORY is a pharmaceutical company with 1 FDA-approved products.
CHANGZHOU PHARMACEUTICAL FACTORY's Key Drugs
CHANGZHOU PHARMACEUTICAL FACTORY's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
CHANGZHOU PHARMACEUTICAL FACTORY's Recent FDA Approvals
New NDA/BLA approvals for CHANGZHOU PHARMACEUTICAL FACTORY over the last two years — novel drugs only, excluding generics and label supplements.
CHANGZHOU PHARMACEUTICAL FACTORY's Therapeutic Areas
Disease areas where CHANGZHOU PHARMACEUTICAL FACTORY has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
CHANGZHOU PHARMACEUTICAL FACTORY Pipeline Snapshot
Active clinical trials for CHANGZHOU PHARMACEUTICAL FACTORY across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- -
- Latest
- -
- Applications
- 2